Compare Tenet Healthcare Corporation (THC) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs State Street SPDR S&P Homebuilders ETF — how do they compare? Tenet Healthcare Corporation trades at $261.07 (market cap $20.98B), while State Street SPDR S&P Homebuilders ETF trades at $95.03 (market cap $1.49B). The key difference: Tenet Healthcare Corporation is far larger — about 14.1× State Street SPDR S&P Homebuilders ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| THC | XHB | |
|---|---|---|
Market Cap | $20.98B | $1.49B |
Volume | 428,008 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $280.77 | $121.36 |
52-Week Low | $161.37 | $94.86 |
Typical Hold Time | 15 Days | 33 Days |
Enterprise Value | $32.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
XHB (SPDR S&P Homebuilders ETF) trades at $94.89, down 2.55% amid broader housing sector pressure from rising mortgage rates. Technical indicators show bearish momentum with moving averages signaling sell pressure, though RSI suggests potential oversold conditions. Recent news highlights institutional interest with Greenland Capital's $17.33 million investment, while new housing legislation and mixed home sales data create uncertainty. The ETF's valuation metrics remain undisclosed in current data.
The housing ETF faces headwinds from 7% mortgage rates but benefits from structural demand and policy support. Near-term performance hinges on interest rate trends and housing market data, with current technical weakness offering potential entry points for long-term housing recovery bets. Key risks include prolonged high rates and economic slowdown impacting buyer affordability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
